Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Shokuhin Eiseigaku Zasshi ; 63(3): 117-121, 2022.
Artículo en Japonés | MEDLINE | ID: mdl-35858796

RESUMEN

Fusarium species infect the major cereals consumed as food and feed, contaminating them with various toxic secondary metabolites known as toxins. Among these toxins, which include trichothecenes, zearalenone (ZEA), and fumonisins, the type-B trichothecene deoxynivalenol (DON) is generally considered as the most important. The present study evaluates an analytical method for the detection and quantification of multiple Fusarium toxins, namely, DON, acetyl forms of DON (3-Ac-DON and 15-Ac-DON), a glycoside form of DON (DON-3G), and other Fusarium toxins (nivalenol, an acetyl form of NIV (fusarenonX), T-2 and HT-2 toxins, diacetoxyscirpenol, and ZEA) in Job's tears and buckwheat.


Asunto(s)
Coix , Fagopyrum , Fusarium , Micotoxinas , Tricotecenos , Zearalenona , Grano Comestible/química , Contaminación de Alimentos/análisis , Fusarium/metabolismo , Micotoxinas/análisis , Micotoxinas/metabolismo , Micotoxinas/toxicidad , Tricotecenos/análisis , Tricotecenos/metabolismo , Tricotecenos/toxicidad , Zearalenona/análisis , Zearalenona/metabolismo , Zearalenona/toxicidad
2.
Phys Chem Chem Phys ; 24(5): 3478-3485, 2022 Feb 02.
Artículo en Inglés | MEDLINE | ID: mdl-35076038

RESUMEN

This study explored unexpected pseudo-hydrogen bond interactions between meso-methyl BODIPYs and pyridine or acridine. NMR spectral evidence indicated that the meso-methyl group and BF2 core of BODIPYs formed C-H⋯N and C-H⋯F-B pseudo-hydrogen bonds with pyridine, respectively. The weak binding strength was attributed to the preferential solvation of pyridine in the vicinity of meso-methyl BODIPYs in cyclohexane. The observations were explained by the formation of pseudo-hydrogen bonds based on the quantum theory of atoms in molecules (QTAIM) formalism. In contrast, acridine binds to BODIPY with a moderate binding strength. QTAIM formalism suggested the existence of the complementary pseudo-hydrogen bonds, which superficially seemed to rationalise the experimental observations. However, extensive NMR experiments have found no discrete geometry for the complex, indicating considerable geometric freedom. This discrepancy suggests that the static pictures based on the QTAIM analyses conflict with the enthalpy-entropy compensation principle in essential thermodynamics.

3.
J Org Chem ; 87(5): 3123-3134, 2022 03 04.
Artículo en Inglés | MEDLINE | ID: mdl-35076237

RESUMEN

To synthesize meso-ethynylene-conjugated porphyrin arrays, the Sonogashira cross-coupling reaction is straightforward to construct the C(sp)-C(sp2) bonds, but the reaction is often accompanied by side reactions such as the Glaser homocoupling. The rate-determining oxidative addition step results in the unexpected kinetic competition with the Glaser homocoupling, which is desired to be circumvented. We here propose two sets of improved strategies for the synthesis of arylene-ethynylene-linked porphyrin arrays from the meso-brominated porphyrin and alkynes. First, we explored the solvent-modulated approach employing dichloromethane as the reaction solvent to minimize the formation of the copper acetylide dimer as the intermediate for the Glaser homocoupling, while the scope of the approach is limited. Subsequently, we have developed the trimethylsilanolate-promoted Hiyama-type approach that activates alkynyl trimethylsilanes (TMSs) by use of potassium trimethylsilanolate under amine-free conditions. The latter approach is advantageous not only in skipping the preprotodesilylation of the TMS group but also in achieving an excellent isolated yield.


Asunto(s)
Porfirinas , Alquinos/química , Cobre , Porfirinas/química , Solventes
4.
J Phys Chem B ; 125(32): 9286-9295, 2021 08 19.
Artículo en Inglés | MEDLINE | ID: mdl-34370467

RESUMEN

The formation of C-F···H-C "hydrogen bonds" has been a controversial subject because, in principle, fluorine is hardly an acceptor for less acidic protons contrasting to the C-F···H-O and C-F···H-N hydrogen bonds. Nevertheless, the interaction is emerging as a powerful implement for confining the torsional rotation in the design of fully coplanar π-conjugated polymers. Heretofore, no evidence of the C-F···H-C interaction has been observed in solutions. We herein disclose comprehensive evidence that the C-F···H-C interaction produces an attractive force. A 19F-1H heteronuclear Overhauser effect experiment elucidated the close proximity of the F and H atoms in the doubly edge-facing C-F···H-C interactions of a meso-tetrafluorophenylene-ethynylene-conjugated porphyrin dimer (1). Extensive electronic and photophysical property investigations confirmed that all the aromatic units were torsionally restricted by the C-F···H-C interactions. Moreover, the enforced coplanarity invoked a markedly high π-staking propensity. Thus, we have firmly established the formation of a C-F···H-C interaction that produces a hydrogen-bond-like attractive force in solution.


Asunto(s)
Porfirinas , Fluorobencenos , Enlace de Hidrógeno , Polímeros , Protones
5.
J Nat Med ; 75(3): 623-632, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33830449

RESUMEN

The anti-inflammatory effects of a 50% aqueous extract of Rosa roxburghii fruit (RRFE) and two ellagitannins (strictinin and casuarictin) isolated from the RRFE were evaluated in a cell model of skin inflammation induced by self-RNA released from epidermal cells damaged by UV ray (UVR) irradiation. The RRFE inhibited interleukin-8 (IL-8) mRNA expression in normal human epidermal keratinocytes (NHEKs) stimulated with polyinosinic:polycytidylic acid (poly(I:C)), a ligand of toll-like receptor-3 (TLR-3). The plant-derived anti-inflammatory agents, dipotassium glycyrrhizinate (GK2) and allantoin, had no influence on the IL-8 expression. The purified compounds, strictinin and casuarictin, inhibited the IL-8 mRNA expression and IL-8 release induced in NHEKs by poly(I:C). These ellagitannins were thus found to be responsible for the biological activity exhibited by the RRFE. This study demonstrates that RRFE and isolated RRFE compounds show promise as ingredients for products formulated to improve skin disorders induced by UVR irradiation.


Asunto(s)
Taninos Hidrolizables/farmacología , Interleucina-8/biosíntesis , Queratinocitos/efectos de los fármacos , Rosa/química , Compuestos de Bifenilo , Células Cultivadas , Frutas/química , Ácido Gálico/análogos & derivados , Humanos , Queratinocitos/metabolismo , Fenoles , Poli I-C/farmacología , Rayos Ultravioleta
6.
Biochem Biophys Res Commun ; 458(4): 856-61, 2015 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-25701783

RESUMEN

Epidermal growth factor receptor (EGFR) mutation is one of the hallmarks of cancer progression and resistance to anticancer therapies, particularly non-small cell lung carcinomas (NSCLCs). In contrast to the canonical EGFR activation in which tyrosine residues are engaged, we have demonstrated that the non-canonical pathway is triggered by phosphorylation of serine and threonine residues through p38 and ERK MAPKs, respectively. The purpose of this study is to investigate the role of non-canonical EGFR pathway in resistance mechanism against cisplatin treatment. Wild type and mutated (exon 19 deletion) EGFR-expressing cells responded similarly to cisplatin by showing MAPK-mediated EGFR phosphorylation. It is interesting that internalization mechanism of EGFR was switched from tyrosine kinase-dependent to p38-dependent fashions, which is involved in a survival pathway that counteracts cisplatin treatment. We therefore introduce a potential combinatorial therapy composed of p38 inhibition and cisplatin to block the activation of EGFR, therefore inducing cancer cell death and apoptosis.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/genética , Cisplatino/farmacología , Receptores ErbB/genética , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Apoptosis/efectos de los fármacos , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Resistencia a Antineoplásicos , Receptores ErbB/metabolismo , Humanos , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Pulmón/patología , Neoplasias Pulmonares/patología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Mutación , Fosforilación/efectos de los fármacos
7.
Cancer Sci ; 104(10): 1315-22, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23822636

RESUMEN

We have recently identified tumor necrosis factor (TNF)-α-induced phosphorylation of epidermal growth factor receptor (EGFR) at Thr-669 and Ser-1046/1047 via ERK and p38 pathways, respectively. In the present study, we investigated the roles of ligand-induced phosphorylation of serine and threonine residues in EGFR-overexpressing MDA-MB-468 breast cancer cells. Epidermal growth factor and heregulin, an ErbB3 ligand, induced the phosphorylation of Thr-669 and Ser-1046/1047. Inversely, constitutive tyrosine phosphorylation of the C-terminal domain, including Tyr-1068, was significantly downregulated on ligand stimulation. Inhibition of the ERK pathway by U0126 blocked ligand-induced Thr-669 phosphorylation as well as Tyr-1068 dephosphorylation. Downregulation of constitutive tyrosine phosphorylation of EGFR in HEK293 cells stably expressing the wild type was abolished by substitution of Thr-669 for Ala. In an asymmetric EGFR homodimer structure, one Thr-669 in the receiver kinase of the dimer was involved in downregulation. Similarly, Thr-669 in an EGFR-ErbB3 heterodimer also participated in tyrosine dephosphorylation. These results indicate that ERK-mediated Thr-669 phosphorylation suppresses constitutive tyrosine phosphosphorylation in the homo- and heterodimer asymmetric conformations of the EGFR.


Asunto(s)
Receptores ErbB/metabolismo , Sistema de Señalización de MAP Quinasas , Proteínas de Neoplasias/metabolismo , Fosfotreonina/metabolismo , Procesamiento Proteico-Postraduccional , Adenocarcinoma/enzimología , Neoplasias de la Mama/enzimología , Butadienos/farmacología , Línea Celular Tumoral/enzimología , Dimerización , Factor de Crecimiento Epidérmico/farmacología , Receptores ErbB/química , Retroalimentación Fisiológica , Femenino , Humanos , Ligandos , Proteínas de Neoplasias/química , Neurregulina-1/farmacología , Nitrilos/farmacología , Fosforilación , Conformación Proteica , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Recombinantes/farmacología , Factor de Necrosis Tumoral alfa/farmacología
8.
Mol Cell Biol ; 29(20): 5529-39, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19687304

RESUMEN

The kinase TAK1, a mitogen-activated protein kinase kinase kinase (MAP3K), has been widely accepted as a key kinase activating NF-kappaB and MAPKs in tumor necrosis factor alpha (TNF-alpha) signaling. We have recently reported that TAK1 regulates the transient phosphorylation and endocytosis of epidermal growth factor receptor (EGFR) in a tyrosine kinase activity-independent manner. In the present study, we found that Thr-669 in the juxtamembrane domain and Ser-1046/1047 in the carboxyl-terminal regulatory domain were transiently phosphorylated in response to TNF-alpha. Experiments using chemical inhibitors and small interfering RNA demonstrated that TNF-alpha-mediated phosphorylation of Thr-669 and Ser-1046/7 were differently regulated via TAK1-extracellular signal-regulated kinase (ERK) and TAK1-p38 pathways, respectively. In addition, p38, but not ERK, was involved in the endocytosis of EGFR. Surprisingly, modified EGFR was essential to prevent apoptotic cellular responses; however, the EGFR pathway was independent of the NF-kappaB antiapoptotic pathway. These results demonstrated that TAK1 controls two different signaling pathways, IkappaB kinase-NF-kappaB and MAPK-EGFR, leading to the survival of cells exposed to the death signal from the TNF-alpha receptor.


Asunto(s)
Receptores ErbB/metabolismo , Quinasas Quinasa Quinasa PAM/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Antracenos/farmacología , Butadienos/farmacología , Inhibidores Enzimáticos/farmacología , Factor de Crecimiento Epidérmico/farmacología , Receptores ErbB/agonistas , Células HeLa , Humanos , Imidazoles/farmacología , Lactonas/farmacología , Quinasas Quinasa Quinasa PAM/antagonistas & inhibidores , FN-kappa B/genética , FN-kappa B/metabolismo , Nitrilos/farmacología , Fosforilación/efectos de los fármacos , Fosforilación/fisiología , Piridinas/farmacología , Quinazolinas/farmacología , ARN Interferente Pequeño/metabolismo , Resorcinoles/farmacología , Serina/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Treonina/metabolismo , Factor de Necrosis Tumoral alfa/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA